D. Ian Hodson - Concepedia

Author

D. Ian Hodson

Also Known As

D I Hodson, D Ian Hodson, D. Hodson, D. I. Hodson, D. Ian Hodson, D.I Hodson, D.I. Hodson, D.I.A.N. Hodson, D.Ian Hodson, I. S. Young

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Cancer Care Ontario Queen's University University of Toronto Hamilton Regional Laboratory Medicine Program Princess Margaret Cancer Centre

About

D. Ian Hodson is an author at Cancer Care Ontario specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.5K
2	Health Sciences	9	9	1K
3	Public Health	1	1	60
4	Biostatistics	1	1	30
5	Head And Neck Surgery	1	1	30

D. Ian Hodson

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. E Rapp, Joseph L. Pater, Andrew R. Willan, Journal of Clinical Oncology OncologyCombination ChemotherapyCancer ManagementMetronomic TherapyClinical Trials	1988	699
Chordoma: The results of megavoltage radiation therapy Bernard Cummings, D. Ian Hodson, R. S. Bush International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMegavoltage Radiation TherapyMedicineSpinal TumorSurgery	1983	238
The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. George P. Browman, Mark N. Levine, D. Ian Hodson, Journal of Clinical Oncology	1993	161
Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. George P. Browman, C. Cripps, D. Ian Hodson, Journal of Clinical Oncology	1994	139
Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback. George P. Browman, Toni Newman, E. Ann Mohide, Journal of Clinical Oncology	1998	130
Management and Outcome Differences in Supraglottic Cancer Between Ontario, Canada, and the Surveillance, Epidemiology, and End Results Areas of the United States Patti A. Groome, Brian O’Sullivan, Jonathan C. Irish, Journal of Clinical Oncology	2003	112
Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. Charles W. Scarantino, Francis G. LeVeque, Ruth Swann, PubMed Radiation MedicineNeck Cancer PatientsRadiation TherapyMedicineOral Cavity	2006	94
Phase III quality-of-life study results: impact on patients’ quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer—RTOG 97-09 Jacquelyn Fisher, Charles Scott, Charles W. Scarantino, International Journal of Radiation OncologyBiologyPhysics Quality Of LifeRadiation MedicineRadiation TherapyMedicineHead-and-neck Cancer—rtog 97-09	2003	90
Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules Patti A. Groome, Brian O’Sullivan, William J. Mackillop, International Journal of Radiation OncologyBiologyPhysics MedicineCompromised Local ControlCancer ManagementIntensified Treatment SchedulesTreatment Planning	2006	77
Explaining Socioeconomic Status Effects in Laryngeal Cancer Patti A. Groome, Karleen Schulze, Simone Keller, Clinical Oncology Cancer EpidemiologySocioeconomic Status EffectsEpidemiology Of CancerSociologyHealth Disparities	2006	60

Page 1